IDH2 and acute myeloid leukemia: This meta-analysis included 12725 AML patients from eleven different centers, of whom 1416 (11.1%) had IDH2 mutations, while 1111 (8.7%) and 305 (2.4%) had IDH2R140 and IDH2R172 mutations, respectively.